# A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

> **NCT06664775** · PHASE3 · RECRUITING · sponsor: **Corza Medical GmbH** · enrollment: 116 (estimated)

## Conditions studied

- Hemorrhage

## Interventions

- **BIOLOGICAL:** TachoSil
- **BIOLOGICAL:** Surgicel Original

## Key facts

- **NCT ID:** NCT06664775
- **Lead sponsor:** Corza Medical GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664775, "A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06664775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*